Anti-inflammatory drugs are used to treat various chronic inflammatory health conditions such as arthritis, asthma, multiple sclerosis, pulmonary fibrosis, etc. They are available in various formulations including tablets, capsules, ointments, injections, etc. Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used anti-inflammatory medications owing to their effectiveness and easy availability without prescription.
The global anti-inflammatory drugs Market is estimated to be valued at US$ 102248.44 Mn in 2023 and is expected to exhibit a CAGR of 8.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing prevalence of chronic inflammatory diseases is one of the key factors driving the growth of anti-inflammatory drugs market. As per estimates, over 54 million Americans suffer from arthritis, 23 million have asthma, and approximately 1 million people in the US have rheumatoid arthritis. With growing geriatric population, cases of arthritis and joint pains are also rising globally. As a result, pharmaceutical companies are investing in research and development of improved anti-inflammatory therapeutics for better treatment and management of chronic conditions. For instance, new targeted immune therapies and biologics are finding applications in diseases like Crohn's, ulcerative colitis, psoriasis etc. This trend is expected to continue during the forecast period.
Segment Analysis
The global anti-inflammatory drugs market is segmented into steroids, non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, interleukin blockers and others. The non-steroidal anti-inflammatory drugs (NSAIDs) segment holds the largest market share owing to its wide usage for treating various inflammatory conditions like arthritis, muscle strains, tendonitis, and menstrual cramps. NSAIDs like ibuprofen and naproxen are available over-the-counter for mild-to-moderate pain and fever relief.
Key Takeaways
The Global Anti-Inflammatory Drugs Market Demand is expected to witness high growth. The market is estimated to reach a value of US$ 152823.56 Mn by 2030 from US$ 102248.44 Mn in 2023, expanding at a CAGR of 8.6% during the forecast period 2023 to 2030.
Regional analysis
North America dominates the global anti-inflammatory drugs market owing to rising incidences of arthritis and autoimmune disorders. According to the Association of Rheumatology Professionals, over 54 million adults in the U.S. suffer from arthritis. The availability of advanced healthcare facilities and high healthcare expenditure contribute to the large market size of North America. Asia Pacific is expected to be the fastest growing regional market during the forecast period driven by increasing aging population, rising healthcare expenditure and growing awareness about inflammatory conditions.
Key players
Key players operating in the anti-inflammatory drugs market are Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson Services Inc., Merck & Company, Inc., Novartis AG, Amgen, Inc., AstraZeneca plc, Eli Lily and Company, AbbVie Inc., F. Hoffmann-La Roche AG, Bristol Myers Squibb Company, Biogen Inc., Sun Pharmaceutical Industries Ltd, Mylan, Inc., Aurobindo Pharma Limited, and Dr. Reddy€TMs Laboratories.
Explorer more information on this topic, Please visit -
